December 2024 in “International Journal of Advanced Research” In this study, the authors concluded that metformin and vitamin D are important for managing PCOS by improving insulin resistance and hormonal imbalances, especially in women with a BMI of 25 kg/m² or higher.
December 2024 in “Deleted Journal” This review explores the challenges of treating chronic wounds and highlights regenerative medicine as a promising approach, emphasizing the roles of growth factors, stem cell therapies, and novel regenerative treatments in improving wound healing and tissue regeneration.
October 2024 in “Skin Appendage Disorders” This bibliometric analysis reported that PRP is most frequently studied for hair restoration, especially in placebo-controlled trials, although differences in PRP preparation and outcome measures challenge result consistency across studies.
September 2024 in “International Journal of Research in Dermatology” This study found that the combination of PRP with topical minoxidil and finasteride showed the most significant improvement in hair pull tests and patient satisfaction for male androgenetic alopecia, surpassing individual therapies and placebo over a six-month period.
September 2024 in “Journal of the American Academy of Dermatology” This meta-analysis found that smoking is significantly associated with increased odds of developing and progressing androgenetic alopecia, with higher risks observed in men smoking at least 10 cigarettes daily.
September 2024 in “Journal of Ayurveda and Integrative Medicine” This case report detailed a 45-year-old woman with diffuse systemic sclerosis who underwent Ayurvedic treatment, leading to reduced depigmentation, new hair growth, and improved well-being over eight weeks. The findings suggest the potential efficacy of a holistic Ayurvedic approach in managing scleroderma symptoms.
September 2024 in “Pigment International” Results are not reported in this abstract; it discusses recent advancements in understanding vitiligo's pathogenesis, treatment, and comorbidities, emphasizing emerging areas like gut microbiome involvement and highlighting the disease's reclassification as a systemic condition with evolving therapies.
This study found a significant association between androgenetic alopecia and metabolic syndrome, with AGA patients showing higher BMI, waist circumference, blood glucose, and cholesterol levels compared to controls.
June 2024 in “International Journal of Cosmetic Science” This study found that various plant oils can penetrate the lipid-rich cell membrane complex of hair, improving its fatigue strength by preventing flaw propagation, with greater penetration observed for oils containing shorter chain lengths and unsaturated fatty acids.
June 2024 in “Indian Journal of Plastic Surgery/Indian journal of plastic surgery” This study found that using a specific ratio method based on the patient's scalp measurements can effectively predict the dimensions of the permanent safe zone for hair transplants, particularly in early stages of androgenetic alopecia, potentially ensuring long-lasting transplant results.
May 2024 in “EAS Journal of Pharmacy and Pharmacology” In this study, researchers used molecular docking to show that compounds from pomegranate peels, such as apigenin, luteolin, and taxifolin, effectively inhibit the enzyme 5α-reductase, suggesting potential anti-alopecic properties.
May 2024 in “Journal of medicinal food” This review highlights jojoba oil's unique composition and its growing therapeutic applications, noting its antioxidant, anti-acne, antidiabetic, and antibacterial properties, as well as its use in various pharmaceutical formulations.
May 2024 in “Pigment International” In a randomized phase 2b clinical trial, oral ritlecitinib significantly reduced facial vitiligo area scores in patients with active nonsegmental vitiligo compared to placebo, with a favorable safety profile observed over 48 weeks, suggesting its potential as an effective treatment option (Ezzedine et al., 2023).
April 2024 in “Clinical and experimental dermatology” This retrospective study evaluated the use of tofacitinib as an induction therapy for severe alopecia areata and found it promising and comparable to the standard oral mini-pulse treatment, though pulse steroids may be considered if tofacitinib response is inadequate.
April 2024 in “Journal of translational medicine” In this study, the researchers identified MJ04, a selective JAK3 inhibitor, as a promising candidate for promoting hair growth, demonstrating efficacy in both animal models and human hair follicle assays with a favorable safety and pharmacokinetic profile.
April 2024 in “Our Dermatology Online” This study found that androgenetic alopecia may be a predictor of metabolic syndrome, emphasizing the importance of screening patients with severe hair loss for related health risks.
March 2024 in “Homoeopathic links” This study reports that acute telogen effluvium, characterized by sudden hair loss occurring 2 to 3 months after a physical stressor, is not widely caused by daily life stress, with spontaneous regrowth usually happening within 3 to 6 months unless the trigger recurs.
January 2024 in “International Research Journal of Modernization in Engineering Technology and Science” This review suggests that combining nanotechnology with herbal components in hair cosmetics may improve the delivery and effectiveness of treatments for issues like damage, dandruff, and hair loss.
January 2024 in “Defence life science journal” This review explores the potential of non-invasive photobiomodulation therapy for managing combat and traumatic soft tissue injuries, emphasizing its benefits, efficacy, and underlying mechanisms, but reports no new clinical results.
November 2023 in “bioRxiv (Cold Spring Harbor Laboratory)” This study found that disrupted cholesterol homeostasis impairs hair regrowth in individuals with primary cicatricial alopecia by damaging hair follicle stem cells, highlighting the importance of cholesterol in maintaining stem cell function and hair follicle integrity.
October 2023 in “Indian Dermatology Online Journal” This case report describes a 1.5-month-old baby with Schimmelpenning-Feuerstein-Mims syndrome, manifested by skin and ocular abnormalities along with developmental delays and hearing loss observed later, highlighting the syndrome's progression and need for multidisciplinary management.
September 2023 in “Biology of reproduction” This study suggests that the testosterone analogs 7α-Methyltestosterone and 7α-Ethyltestosterone may offer promising androgenic, progestogenic, and anabolic properties for development as male contraceptives.
September 2023 in “Journal of the American Academy of Dermatology” This study found that obese pediatric patients with confluent and reticulated papillomatosis responded less effectively to treatment compared to non-obese patients.
August 2023 in “International Journal For Multidisciplinary Research” This case study reported that using the ayurvedic treatment protocol of Nitya Virechana, Kulatthadi Kashaya, and Shatapushpa Churna was associated with improved menstrual regularity, reduced obesity, and decreased symptoms of hirsutism and acne in a 19-year-old woman with PCOD.
August 2023 in “Drug Delivery and Translational Research” Human hair keratin was used to create a scaffold that could help with skin repair.
June 2023 in “International Journal of Research in Dermatology” In this study, obese patients who underwent bariatric surgery experienced significant weight loss, which was associated with improvements in certain skin conditions, such as intertrigo, tinea corporis, and striae rubra, although the prevalence of many other skin diseases remained unchanged.
May 2023 in “Animal Reproduction Update” This article reviews the use of hair cortisol concentration as a biomarker to assess long-term stress in both animals and humans, but it reports no new experimental results.
February 2023 in “Molecules” In this study, N. ottonis cactus cell extract applied to mice promoted hair growth and increased the number of hair follicles, suggesting its potential as a hair-growth-promoting agent.
January 2023 in “International Journal of Pharmaceutical Research and Development” This review discusses alopecia, its pathophysiology, nanotechnology-based drug delivery systems, and related quality of life issues, without reporting new clinical results.
January 2023 in “National Journal of Physiology, Pharmacy and Pharmacology” In this study, tofacitinib treatment for six months significantly reduced hair loss severity in alopecia areata patients.